Format

Send to

Choose Destination
ACS Med Chem Lett. 2019 Apr 29;10(5):694-695. doi: 10.1021/acsmedchemlett.9b00127. eCollection 2019 May 9.

CBD: A New Hope?

Author information

1
Instituto de Química Médica, Consejo Superior de Investigaciones Científicas, Madrid 28006, Spain.
2
Chemistry and Biochemistry Department, UNC Greensboro, Greensboro, North Carolina 27412, United States.

Abstract

The nonpsychoactive phytocannabinoid, CBD, was recently approved by the Food and Drug Administration for the treatment of children with drug-resistant epilepsy. This milestone opens new avenues for cannabinoid research. In this Viewpoint, we provide an overview of recent progress in the field highlighting molecular insights into CBD's mechanism of action, as well as its therapeutic potential.

PMID:
31097982
PMCID:
PMC6511966
[Available on 2020-05-09]
DOI:
10.1021/acsmedchemlett.9b00127

Supplemental Content

Full text links

Icon for American Chemical Society
Loading ...
Support Center